Skip to content

The research and development of gentamicin topical preparation and the study on the readthrough effect in children with genodermatosis

The research and development of gentamicin topical preparation and the study on the readthrough effect in children with genodermatosis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069011
Enrollment
Unknown
Registered
2023-03-03
Start date
2020-11-17
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genodermatosis Caused by Nonsense Mutations

Interventions

right-side medication group:right-side 0.1% gentamicin ointment Bid
left-side medication group:left-side 0.1% gentamicin ointment Bid

Sponsors

Beijing Children’s Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1) Genodermatosis such as EB and NPPK were diagnosed by clinical and genetic tests in our hospital,carried with nonsense mutations; 2) Stable vital signs; 3) The subject or guardian signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Patients with a history of allergy to aminoglycosides; 2) Patients with other chronic concomitant diseases or infectious diseases; 3) Impairment of VIII nerves, deafness gene mutation through gene screening, or hearing impairment; 4) Abnormal ECG, chest X-ray, ultrasound, liver and kidney functions; 5) Other conditions, or poor compliance.

Design outcomes

Primary

MeasureTime frame
clinical manifestation;Birmingham Epidermolysis Bullosa Severity (BEBS) score;

Secondary

MeasureTime frame
dermatology life quality index (DLQI);

Countries

China

Contacts

Public ContactLin Ma

Beijing Children’s Hospital, Capital Medical University

bch_maleen@aliyun.com13601305676

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026